TTBK2 and melanoma: For lung adenocarcinoma, on the other hand, TTBK2 was expressed relatively more in tissue samples from subjects without recurrence after 5 years than those with recurrence within 3 years [37], suggesting a somewhat different involvement of TTBK2 in lung adenocarcinoma than in kidney carcinoma and melanoma.